Saudi Arabia:
On 27 February 2020 a Saudi nationality person returning to Saudi Arabia
via Bahrain from Iran without knowing that he has infected but on 2
March, Saudi
Arabia reported that the man has infected with SARS-COVID 19. This made
Saudi Arabia announce a temporary lockdown of the
Great Mosque
of Mecca and
the Prophet’s
Mosque in Madinah but
later they decided to reopen the mosques only except for the Great
Mosque of Mecca, with the very preventive health measure against the
virus. To prevent further outbreaks of the infection Saudi Arabia
Government announced a travel ban between the Kingdom and China, and
they decided to suspend the entry of other cooperation council citizens
into the country and vice versa. And later they counseled all internal
flights, trains, buses, taxis for only 14 days like a big effort to
obstacle the COVID19 spreading.
Saudi
Arabia’s health ministry has approved the use of the steroid
dexamethasone as part of its treatment protocol for COVID-19 patients,
Saudi Press Agency reported on Wednesday Dexamethasone has been used to
treat inflammation in diseases such as arthritis. (WHO) said on
Wednesday it would be updating its clinical guidelines on COVID-19
treatment to include the results of the preliminary trial conducted by
University of Oxford researchers
The Russian Direct Investment Fund (RDIF), the country’s sovereign
wealth fund which has collaborated with the Kingdom on many investment
projects, is set to unveil the new drug, Avifavir, at a virtual press
conference in Moscow. RDIF said that the drug, which ”has shown high
efficacy in treating patients with coronavirus during clinical trials,”
had received a registration certificate from the Russian health
ministry. Our partners expressed interest in starting a clinical trial
of Avifavir in the Kingdom.” The affair, which disrupts the reproduction
mechanisms of coronavirus, Favipiravir is a drug that has proven
effective in the treatment of infected patients in China and clinical
trials in Russia.